Trendlines celebrates 10 years 2007-2017

As we enter our second decade, we remain committed to “improving the human condition” by inventing, investing in, and incubating early-stage, breakthrough medical and agricultural technologies in IsraelSingapore, and beyond.

Editor’s note: News of our 10-year anniversary appeared in Bloomberg, Yahoo! Finance, TheStreet, and numerous media outlets.


10 Years by the Numbers

  • Established 75 portfolio companies
  • Reached a portfolio value of $84 million
  • Completed 6 exits and taken 2 companies public
  • Received more than 15 awards, including two Best Incubator awards
  • Organized/initiated 28 conferences and road shows
  • Signed collaboration agreements with a number of multinational corporations, including B. Braun and Bayer

We are marking our 10th anniversary of activity this year and look forward to another decade of achievements.


“Showcasing” our portfolio

In our 10th year of activity as the owner of award-winning medical and agtech technologies incubators, The Trendlines Group will hold its 7th Annual Trendlines Company Showcase on 29 March 2017, featuring nine of its portfolio companies presenting to investors, entrepreneurs, and industry leaders from IsraelSingaporeChinathe United States, and more.

Trendlines’ 2016 event drew a record 450 participants. Uri Levine, serial entrepreneur and co-founder of Waze, will give the keynote address, “Passion for Entrepreneurship.”

Trendlines by the numbers: In 2010, Trendlines held its 1st Annual Trendlines Company Showcase in Israel, with 100 participants.

From Chicago to Shorashim

While Trendlines Chairmen and CEOs Steve Rhodes and Todd Dollinger both grew up in Chicago, they met in Israel 26 years ago, at a place they and their families still call home, Moshav Shorashim in the Western Galilee. That’s where the Trendlines story begins.

Recognizing the need to assist Israeli companies in “going global,” and drawing on decades of experience in finance (Steve) and business development (Todd), they founded Trendlines International as a business development firm focused on assisting and guiding innovation-based Israeli companies in the complex U.S. market. Todd and Steve were among the pioneers in Israel’s high-tech start-up nationhood.

From the Hills of the Galilee to the Shores of Singapore

Ten years ago, Steve and Todd established The Trendlines Group to acquire the incubators now known as Trendlines Medical and Trendlines Agtech, two incubators that operate under license from the Israeli government. Trendlines completed its evolution from consulting to investing after the formation of The Trendlines Group and brought forward our vision of “creating and developing companies to improve the human condition,” with our mission focused on investments on early-stage medical device and agricultural technologies. Our success over the past decade has earned us our reputation as an innovator and leader in our fields.

From 10 employees in 2007, we now employ 40 people in Israel, Singapore, and China. In keeping with our business model, we provide our 46 portfolio companies with intensive hands-on support in finance, business development, technology development, marketing communications, and human resources — every aspect necessary to the success.

Trendlines and our portfolio companies regularly appear in the international media. Steve, Todd, and members of our staff speak at conferences around the world on innovation, entrepreneurship, and early-stage investing.

Trendlines by the numbers: From 100 square meters of office and laboratory space in Misgav, Israel, to 2,620 meters of office space in Misgav, Ramat Gan, and Singapore.

As a natural extension of their leadership in early-stage investing, Todd and Steve took the Company public on the Singapore Exchange in November 2015, raising approximately SGD$38 million in IPO-related financing. In 2016, we established Trendlines Medical Singapore, leveraging partnerships with B. Braun, the government of Singapore, and investment bank PrimePartners, to create and develop innovation-based medical device companies with a view toward global market success.

Trendlines by the numbers: More than 15 awards to Trendlines’ incubators, portfolio companies, and CEOs in Israel and abroad.

Putting Israeli Agtech on the Map

To support our commitment to invest in agricultural technologies, in 2011, Trendlines Agtech became the first and only incubator in Israel to focus solely on this sector. At that time, agtech investments lagged behind other sectors (even in Israel, historically an agtech powerhouse). The global investment community has recently woken up to the immense opportunities in this critical market. We have been an important force in creating and nurturing a burgeoning agtech ecosystem for Israeli start-ups by bringing together vital elements necessary to support and build agtech investing: entrepreneurs, multinationals, and investors.

We co-initiated the first AgriVest event in 2012 when 100 attendees gathered to learn about the fledgling sector. By the 4th AgriVest conference in 2016, it was recognized as the must-attend event for anyone who is anyone in the international agtech arena.

The 2016 conference at the Weizmann Institute of Science attracted over 400 attendees from around the globe and, more importantly, Trendlines and AgriVest placed Israeli agtech firmly on the map of investors and industry players.

Expanding Business Diversity

We established our in-house innovation center, Trendlines Labs, to invent products and technologies to resolve unmet medical and agricultural needs for Trendlines and its strategic partners. Trendlines Labs has established collaboration agreements with Israel’s two largest hospitals as well as hospitals in the United States and Singapore. Trendlines Labs has executed partnering agreements with multinational companies in Europe, the United States, and Asia.